John Woock's Insider Trades & SAST Disclosures
John Woock's most recent trade in Axonics Inc was a trade of 77,403 Common Stock done at an average price of $71 . Disclosure was reported to the exchange on Nov. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Woock.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale or transfer of securities back to the company at price $ 71.00 per share. | 15 Nov 2024 | 77,403 | 0 (0%) | 0% | 71 | 5,495,613 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 15,555 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 13,125 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 3,581 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 28,000 | 93,302 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | Woock John | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 17,500 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | Woock John | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 67.74 per share. | 31 Jan 2024 | 15,899 | 77,403 (0%) | 0% | 67.7 | 1,076,933 | Common Stock |
| Axonics Inc | Woock John | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 10,500 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 22,125 | 76,851 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 17,500 | 17,500 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 11,250 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 10,875 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 8,750 | 54,726 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 8,750 | 8,750 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 31 Jan 2023 | 4,181 | 69,281 (0%) | 0% | 61.1 | 255,551 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 61.02 per share. | 31 Jan 2023 | 3,398 | 65,302 (0%) | 0% | 61.0 | 207,332 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 61.17 per share. | 31 Jan 2023 | 3,389 | 73,462 (0%) | 0% | 61.2 | 207,303 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 60.44 per share. | 31 Jan 2023 | 581 | 68,700 (0%) | 0% | 60.4 | 35,113 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 15,000 | 15,555 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 67.29 per share. | 17 Jan 2023 | 15,000 | 45,976 (0%) | 0% | 67.3 | 1,009,385 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 17 Jan 2023 | 15,000 | 60,976 (0%) | 0% | 14.2 | 212,850 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 12,044 | 3,581 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 67.32 per share. | 17 Jan 2023 | 12,044 | 45,976 (0%) | 0% | 67.3 | 810,772 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.82 per share. | 17 Jan 2023 | 12,044 | 58,020 (0%) | 0% | 25.8 | 310,976 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 2,793 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 17 Jan 2023 | 2,793 | 48,769 (0%) | 0% | 1.3 | 3,687 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 67.62 per share. | 17 Jan 2023 | 2,793 | 45,976 (0%) | 0% | 67.6 | 188,855 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 378 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Sale of securities on an exchange or to another person at price $ 67.51 per share. | 17 Jan 2023 | 378 | 45,976 (0%) | 0% | 67.5 | 25,519 | Common Stock |
| Axonics Inc | John Woock | EVP, Chief Mktg/Strtgy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 17 Jan 2023 | 378 | 46,354 (0%) | 0% | 1.4 | 537 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 08 Sep 2022 | 3,800 | 49,776 (0%) | 0% | 1.4 | 5,396 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 75.01 per share. | 08 Sep 2022 | 3,800 | 45,976 (0%) | 0% | 75.0 | 285,024 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 3,800 | 378 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 08 Sep 2022 | 3,700 | 49,676 (0%) | 0% | 1.6 | 6,031 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 08 Sep 2022 | 3,700 | 45,976 (0%) | 0% | 75 | 277,500 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 3,700 | 0 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 21,425 | 46,357 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 20,870 | 67,227 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 10,875 | 10,875 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 10,870 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 10,000 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 48.21 per share. | 31 Jan 2022 | 5,934 | 61,293 (0%) | 0% | 48.2 | 286,080 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 5,250 | 5,250 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 49.03 per share. | 31 Jan 2022 | 317 | 60,976 (0%) | 0% | 49.0 | 15,544 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share. | 15 Nov 2021 | 5,000 | 29,932 (0%) | 0% | 14.2 | 70,950 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 5,000 | 30,555 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 60.73 per share. | 15 Nov 2021 | 2,984 | 24,932 (0%) | 0% | 60.7 | 181,212 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 15 Nov 2021 | 2,016 | 27,916 (0%) | 0% | 60.1 | 121,209 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 74.73 per share. | 01 Sep 2021 | 8,443 | 26,489 (0%) | 0% | 74.7 | 630,915 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 01 Sep 2021 | 5,000 | 34,932 (0%) | 0% | 1.6 | 8,150 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 3,443 | 12,757 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 75.58 per share. | 01 Sep 2021 | 1,557 | 24,932 (0%) | 0% | 75.6 | 117,677 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 1,557 | 11,200 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 66.85 per share. | 17 Aug 2021 | 13,501 | 36,033 (0%) | 0% | 66.8 | 902,513 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 68.04 per share. | 17 Aug 2021 | 5,901 | 30,132 (0%) | 0% | 68.0 | 401,496 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 66.18 per share. | 17 Aug 2021 | 5,398 | 49,534 (0%) | 0% | 66.2 | 357,234 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 69.05 per share. | 17 Aug 2021 | 200 | 29,932 (0%) | 0% | 69.1 | 13,810 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 51.20 per share. | 25 Feb 2021 | 5,229 | 54,932 (0%) | 0% | 51.2 | 267,750 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 50.40 per share. | 25 Feb 2021 | 4,771 | 60,161 (0%) | 0% | 50.4 | 240,445 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 10,000 | 10,000 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 52.75 per share. | 28 Jan 2021 | 7,571 | 63,319 (0%) | 0% | 52.7 | 399,338 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 53.69 per share. | 28 Jan 2021 | 7,129 | 56,190 (0%) | 0% | 53.7 | 382,755 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 5,625 | 61,515 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 5,625 | 5,625 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 5,334 | 66,849 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 2,667 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 51.36 per share. | 28 Jan 2021 | 1,917 | 64,932 (0%) | 0% | 51.4 | 98,466 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 54.43 per share. | 28 Jan 2021 | 300 | 55,890 (0%) | 0% | 54.4 | 16,329 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 5,435 | 72,783 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 5,435 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 53.58 per share. | 26 Jan 2021 | 1,893 | 70,890 (0%) | 0% | 53.6 | 101,421 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2020 | 10,000 | 4,178 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 27 Nov 2020 | 10,000 | 77,348 (0%) | 0% | 1.4 | 14,200 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 44.94 per share. | 27 Nov 2020 | 7,500 | 67,348 (0%) | 0% | 44.9 | 337,061 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 43.79 per share. | 27 Nov 2020 | 2,400 | 74,948 (0%) | 0% | 43.8 | 105,107 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 45.49 per share. | 27 Nov 2020 | 100 | 74,848 (0%) | 0% | 45.5 | 4,549 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 43.45 per share. | 28 Aug 2020 | 5,000 | 72,348 (0%) | 0% | 43.5 | 217,267 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2020 | 5,000 | 2,793 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.63 per share. | 28 Aug 2020 | 5,000 | 72,348 (0%) | 0% | 1.6 | 8,150 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2020 | 5,000 | 16,200 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | John Woock | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 43.45 per share. | 28 Aug 2020 | 5,000 | 67,348 (0%) | 0% | 43.5 | 217,251 | Common Stock |
| Axonics Inc | John Woock | Chief Marketing Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.32 per share. | 28 Aug 2020 | 5,000 | 77,348 (0%) | 0% | 1.3 | 6,600 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges